Guardian Wealth Advisors LLC Has $296,000 Position in The Clorox Company $CLX

Guardian Wealth Advisors LLC lessened its holdings in shares of The Clorox Company (NYSE:CLX) by 13.1% in the second quarter, according to its most recent filing with the SEC. The firm owned 2,467 shares of the company’s stock after selling 373 shares during the period. Guardian Wealth Advisors LLC’s holdings in Clorox were worth $296,000 as of its most recent filing with the SEC.

A number of other large investors also recently made changes to their positions in CLX. American National Bank & Trust increased its holdings in Clorox by 69.5% in the second quarter. American National Bank & Trust now owns 217 shares of the company’s stock valued at $26,000 after purchasing an additional 89 shares during the last quarter. Ransom Advisory Ltd bought a new stake in shares of Clorox in the 1st quarter valued at about $35,000. GW&K Investment Management LLC increased its stake in shares of Clorox by 239.1% in the 1st quarter. GW&K Investment Management LLC now owns 295 shares of the company’s stock valued at $43,000 after acquiring an additional 208 shares during the last quarter. Bogart Wealth LLC raised its position in shares of Clorox by 289.5% in the 2nd quarter. Bogart Wealth LLC now owns 370 shares of the company’s stock valued at $44,000 after acquiring an additional 275 shares during the period. Finally, Ameritas Advisory Services LLC bought a new position in Clorox during the 2nd quarter worth approximately $48,000. Institutional investors and hedge funds own 78.53% of the company’s stock.

Insiders Place Their Bets

In other Clorox news, COO Eric H. Reynolds sold 15,041 shares of the business’s stock in a transaction that occurred on Thursday, September 4th. The stock was sold at an average price of $123.78, for a total transaction of $1,861,774.98. Following the transaction, the chief operating officer owned 54,221 shares of the company’s stock, valued at $6,711,475.38. The trade was a 21.72% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. 0.63% of the stock is currently owned by corporate insiders.

Clorox Stock Performance

Shares of CLX opened at $116.02 on Friday. The stock has a market capitalization of $14.13 billion, a price-to-earnings ratio of 17.79, a PEG ratio of 0.96 and a beta of 0.52. The Clorox Company has a 12 month low of $115.83 and a 12 month high of $171.37. The firm has a fifty day simple moving average of $121.18 and a 200 day simple moving average of $126.94. The company has a current ratio of 0.84, a quick ratio of 0.57 and a debt-to-equity ratio of 5.15.

Clorox (NYSE:CLX) last issued its quarterly earnings results on Thursday, July 31st. The company reported $2.87 EPS for the quarter, topping the consensus estimate of $2.24 by $0.63. Clorox had a net margin of 11.40% and a return on equity of 377.86%. The firm had revenue of $1.99 billion for the quarter, compared to analysts’ expectations of $1.94 billion. During the same period in the previous year, the firm posted $1.82 EPS. The company’s revenue for the quarter was up 4.5% on a year-over-year basis. Clorox has set its FY 2026 guidance at 5.950-6.30 EPS. Research analysts forecast that The Clorox Company will post 7.15 EPS for the current fiscal year.

Clorox Announces Dividend

The business also recently declared a quarterly dividend, which will be paid on Thursday, November 6th. Shareholders of record on Wednesday, October 22nd will be paid a $1.24 dividend. This represents a $4.96 dividend on an annualized basis and a yield of 4.3%. The ex-dividend date is Wednesday, October 22nd. Clorox’s dividend payout ratio (DPR) is currently 76.07%.

Wall Street Analyst Weigh In

Several equities analysts recently issued reports on the company. Weiss Ratings reiterated a “hold (c-)” rating on shares of Clorox in a research report on Tuesday, October 14th. JPMorgan Chase & Co. reduced their price target on shares of Clorox from $135.00 to $127.00 and set a “neutral” rating for the company in a report on Friday, October 10th. Barclays dropped their price objective on shares of Clorox from $118.00 to $112.00 and set an “underweight” rating on the stock in a report on Tuesday, September 30th. Deutsche Bank Aktiengesellschaft cut their price objective on shares of Clorox from $135.00 to $128.00 and set a “hold” rating on the stock in a research report on Monday, October 13th. Finally, Zacks Research upgraded Clorox from a “strong sell” rating to a “hold” rating in a report on Monday, September 29th. One equities research analyst has rated the stock with a Buy rating, twelve have issued a Hold rating and four have assigned a Sell rating to the company. According to MarketBeat.com, Clorox currently has an average rating of “Reduce” and an average target price of $130.20.

Clorox Profile

The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment offers cleaning products, such as laundry additives and home care products primarily under the Clorox, Clorox2, Scentiva, Pine-Sol, Liquid-Plumr, Tilex, and Formula 409 brands; professional cleaning and disinfecting products under the CloroxPro and Clorox Healthcare brands; professional food service products under the Hidden Valley brand; and vitamins, minerals and supplement products under the RenewLife, Natural Vitality, NeoCell, and Rainbow Light brands in the United States.